Tofacitinib vs Ziprasidone Mesylate

## Tofacitinib vs Ziprasidone Mesylate: Overview

This comparison examines the pharmacological differences between **Tofacitinib** and **Ziprasidone Mesylate**.

## Mechanism of Action

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Tofacitinib — 3.2 hours; Ziprasidone Mesylate — N/A.

## Chemical Properties

**Molecular Formula**: Tofacitinib — C16H20N6O; Ziprasidone Mesylate — N/A.

**Molecular Weight**: Tofacitinib — 312.3700 g/mol; Ziprasidone Mesylate — N/A.

**Type**: Tofacitinib — Small molecule; Ziprasidone Mesylate — Small molecule.